Wisconsin Urology at the 2016 AUA Annual Meeting
The American Urological Association (AUA) 2016 Annual Meeting will take place May 6-10 in San Diego, California.
The University of Wisconsin Department of Urology’s annual Alumni and Friends Reception will take place Sunday, May 8 at the San Diego Marriott Marquis from 5:30-7:30 pm in the Oceanside Room (1st floor, South Tower). We hope to see you there!
The following is a list of meetings, presentations and other events in which our faculty will be involved.
David F. Jarrard, MD, will speak on “Gaining and Sustaining Grant Funding” during the Society of University Urologists (SUU) meeting, Thursday, May 5.
Stephen Y. Nakada, MD, is this year’s President-Elect and Program Chair for the Society of University Urologists/Society of Urology Chairpersons and Program Directors (SUU/SUCPD) Meeting, Thursday, May 5.
Sara L. Best, MD, will serve as a panelist for Contemporary Cases in Endourology at the Society of Women in Urology (SWIU): Women Leaders in Urology Forum, Saturday, May 7.
Sara L. Best, MD, will moderate the session “Emerging High-Impact Technologies”* and speak on *“Second-Harmonic Generation Imaging for Cancer: Urologic Applications” during the Engineering and Urology Society (EUS) – Section of the Endourological Society, Saturday, May 7.
Stephen Y. Nakada, MD, is this year’s President of the Research on Calculus Kinetics (R.O.C.K.) Society. During the meeting, Dr. Nakada will moderate the session “Latest on Surgical Management of Stones” and will be a debater for “Is MET for All Stones?” Monday, May 9.
Kristina L. Penniston, PhD, will speak on “Best Nutritional Assessment Tools” at the Research on Calculus Kinetics (ROCK) Society meeting, Monday, May 9.
Courses, Lectures, Forums and Panels
Stephen Y. Nakada, MD, is the director of the instructional course “Urolithiasis: Surgical Management, Percutaneous, Shock Wave Lithotripsy and Ureteroscopy – How We Do It,” Friday, May 6. Dr. Nakada’s course offers the practicing urologist a comprehensive, case-based review of the surgical management of urolithiasis. Leading experts in the field of urology will present the latest techniques and innovations in percutaneous renal surgery, ureteroscopy, and shock wave lithotripsy.
Patrick H. McKenna, MD, is a presenter for the Academic Development postgraduate course “Surgeons as Educators: A Primer for Academic Development and Teaching Excellence,” Saturday, May 7. This course seeks to give insight and physical tools to improve urologists as educators.
David F. Jarrard, MD, will participate as a panelist in Plenary I: “Evaluating Elevated PSA after a Negative Biopsy,” Sunday, May 8.
E. Jason Abel, MD, is a presenter for the instructional course “Management of Locally Advanced and Metastatic Renal Cell Carcinoma: A Case-Based Approach,” Sunday, May 8. This course offers a series of didactic lectures framed by relevant clinical case scenarios presented to highlight the surgical issues associated with the management of locally advanced and metastatic renal cell carcinoma.
Kristina L. Penniston, PhD, is a moderator for the Podium abstract session "Stone Disease: Medical & Dietary Therapy,” Sunday, May 8.
Sara L. Best, MD, is a presenter on the postgraduate course “Urolithiasis: Metabolic Evaluation and Medical Treatment," Sunday, May 8. This course reviews the pathophysiology of stone disease with a focus on the metabolic and environmental risk factors that lead to stone formation.
Wade Bushman, MD, PhD, will participate in the forum Challenges for Urologic Research: Diabesity speaking on “Diabesity and LUTS,” Sunday, May 8.
Patrick H. McKenna, MD, is a presenter for the Plenary I panel discussion “Health Policy: Utilization of Advanced Practice Providers to Address the Workforce Shortage in Urology,” Sunday, May 8.
Stephen Y. Nakada, MD, will participate in “Crossfire: Controversies in Urology: Benign” as a moderator for “Alpha Blockers Have No Role in Renal Colic” during Plenary I, Sunday, May 8.
Sara L. Best, MD, will act as a defendant for “Case 1: Ureteral Avulsion” in the Plenary II “Court is in Session: Clinical Lessons through a Legal Lens,” Monday, May 9.
Kristina L. Penniston, PhD, is a presenter on the instruction course “Nutrition Counseling for the Prevention of Urolithiasis,” Monday, May 9. This course reviews the different stone-forming mechanisms as they pertain to dietary management. Specifically, methods for prevention of different stone types by nutritional counseling will be presented.
Daniel H. Williams IV, MD, is a Plenary I panelist for “Complex Cases: Chronic Orchialigia,” Tuesday, May 10.
Podium and Poster Abstract Presentations
UW Urology faculty, staff and residents have 22 accepted abstracts for either podium or poster presentation at the 2016 AUA annual meeting. Abstract titles and authors are listed below.
Identifying mRCC Patients Who Are Likely to Benefit from Cytoreductive Nephrectomy with Tumor Thrombectomy.
E Jason Abel, K Zargar, V Margulis, MA Mann, PE Spiess, K Ashouri, L Borregales, A Haddad, C Rew, G Chen, F Shi, S Matin, CG Wood, JA Karam
Preliminary In Vitro Comparison of Fixed and Variable Pulse Laser: Evidence for Decreased Retropulsion and Shortened Fragmentation Time
John Roger Bell, Kristina L Penniston, Sara L Best, Stephen Y Nakada
Automated Stone Volume Measurement Using Reduced-Dose (RD) CT Is Comparable Standard-Dose (SD) CT
John Roger Bell, Amy Lim, Perry Pickhardt, Stephen Y Nakada
Moderate Chronic Kidney Disease (eGFR <60 ml/min) Predicts Recurrence and Progression in Bladder Cancer Patients Treated with Transurethral Resection
Michael L Blute, Jr, Victor Kucherov, Daniel D Shapiro, Timothy J Rushmer, Fangfang Shi, Benjamin Fuller, Kyle A Richards, E Jason Abel, David F Jarrard, Edward M Messing, Tracy M Downs
Nomogram to Predict Recurrence in Non-metastatic RCC with Thrombus Using a Multi-center Contemporary Series
ML Blute Jr., TA Masterson, VA Master, V Margulis, CA Lorentz, TM Bauman, JA Karam, CG Wood, EJ Abel
Presence of Bland Thrombus Is a Negative Indicator for Cancer Specific Survival in Patients Undergoing Nephrectomy for Kidney Tumors with Venous Tumor Thrombus
Gong Chen, Charles Rew*, Ryan Hutchinson, Nirmish Singla, Kunj Sheth, Matthew Meissner, Ahmed Haddad, Michael Mann, E. Jason Abel, Vitaly Margulis, Dallas, TX, R. Houston Thompson
Dr. Joseph Bell: Surgical Sleuth and the Inspiration behind Sherlock Holmes
Tracy M Downs, Sutchin R Patel
Vitamin D: From Its Discovery to “Sunshine Beer” to Its Role in Urology
Tracy M Downs, Kristina L Penniston, Sutchin R Patel, Stephen Y Nakada
Comparing Outcomes for Percutaneous Microwave Ablation, Cryoablation and Surgery for Treatment of Sporadic RCC ≤ 4cm
MD Grimes, TA Wittmann, SL Best, JL Hinshaw, FT Lee Jr., MG Lubner, TJ Ziemlewicz, SA Wells, SY Nakada, EJ Abel
A Critical Analysis of Postoperative Morbidity in Morbidly Obese Patients Following Renal Cancer Surgery
MD Grimes, ML Blute Jr., MA Mann, TM Downs, F Shi, DF Jarrard, SL Best, KA Richards, SY Nakada, EJ Abel
Phase IIa, Randomized Placebo-controlled Trial of Single High Dose Cholecalciferol (vitamin D3) and Daily Genistein (G-2535) Versus Placebo in Men with Early Stage Prostate Cancer Undergoing Prostatectomy
David Jarrard, Badrinath R. Konety, Joel Slaton, Wei Huang, Tracy Downs, Jill Kolesar, KyungMann Kim, Tom Havighurst, Margaret G. House, Howard L. Parnes, Howard H Bailey
Evaluating Robotic Operative Experience: How Suture Integrity Can Assess a Surgeon’s Proficiency
Tim Large, Alison Keenan, William Bennett Jr, Mark Cain, Richard Rink, Benjamin Whittam
Clinical Use of Patient Decision-Making Aids for Management Decisions in Stone Patients: A Shared Decision-Making Approach
Amy Lim, Necole M Streeper, Stephen Y Nakada, Sara L Best, Kristina L Penniston
Orchiectomy Following Microsurgical Denervation of the Spermatic Cord: Single Institution Review
Kathryn Lipscomb, Daniel H Williams
Synthetic Lethal Metabolic Targeting of Cellular Senescence in Prostate Cancer with the Repurposed Drug Metformin
Johnathon McCormick, Michael L Blute, Jr., Bing Yang, Nathan Damaschke, David F Jarrard
Impact of Apology Laws on Litigation Length
Patrick H McKenna, Thomas W Bentley, Christina J Sauder
The North American Quality of Life Stone Consortium: Follow-up Results from a Prospective, Longitudinal, Multi-Center Validation Study of the Health-Related Quality of Life of Patients with Kidney Stones
Kristina L Penniston, Madison, WI, Lauren E Tennyson*, Timothy D Averch, Pittsburgh, PA, Davis P Viprakasit, Chapel Hill, NC, Jodi A Antonelli, Dallas, TX, Sriharan Sivalingam, Cleveland, OH, Roger L Sur, San Diego, CA, Ben H Chew, Vancouver, Canada, Vernon M Pais Jr, Hanover, NH, Vincent G Bird, Gainesville, FL, Stephen Y Nakada, Madison, WI
Prospective, Randomized, Double Blind, Vehicle Controlled, Mulinational, Phase 3 Clinical Trial of the Pore Forming Protein PRX302 for Targeted Treatment of Symptomatic Benign Prostatic Hyperplasia
Claus Roehrborn, Dallas, TX; Reg Bruskewitz, Madison, WI; Richard Yocum, La Jolla, CA; Allison Hulme, La Jolla, CA; Marc Gittelman, Aventura, FL
Cystine Stone-Formers Have Impaired Health Related Quality of Life Compared to Non-Cystine Stone-Formers
Necole M Streeper, Margaret L Wertheim, Kristina L Penniston, Stephen Y Nakada
Preliminary Evidence Suggests Periureteral Botulinum Toxin Type A Injection Improves Ureteral Stone Passage in the Porcine Model
Necole M Streeper, Stephen Y Nakada, Margaret L Wertheim, Sara L. Best
Comparison of a Novel Combined Holmium Laser and Suction Device, LithAssist, to an Ultrasonic Lithotripter for Percutaneous Nephrolithotomy- A Randomized Controlled Multicenter Clinical Trial
Necole M Streeper, Zhamshid Okhunov, Jaime Landman, John Roger Bell, Sara L Best, Stephen Y Nakada
Can We Rely on Pyuria as a Marker for UTI in the Neurogenic Bladder? An 11-year Longitudinal Analysis
Ruthie Su, Mari Palta, Amy Lim, Christina Sauder, Ellen Wald